2025 · 4th Quarter (Oct 1 - Dec 31)

INCYTE CORPORATION

Filed by INCYTE CORPORATION.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: Not reported
Expenses: $530,000.00
Registrant: INCYTE CORPORATION
Client: INCYTE CORPORATION
Filing UUID: d33218b0-e347-4bb3-b650-f54c2bbc5de5
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

H.R. 946/S. 1862, Orphan Cures Act implementation H.R. 1262 Give Kids a Chance Act Issues related to Medicaid rebates Issues related to Medicaid coverage of new drugs Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology

Literal federal measure citations: H.R. 946, S. 1862, H.R. 1262

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.